iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025

Core Viewpoint - iCAD, Inc. is set to release its financial results for Q4 and the full year of 2024 on March 19, 2025, and will host a conference call to discuss these results [1]. Company Overview - iCAD, Inc. is a global leader in AI-powered cancer detection solutions, aiming to enhance early cancer detection and improve patient outcomes [2]. - The company's ProFound Breast Health Suite offers AI-driven mammography analysis for breast cancer detection, density assessment, and risk evaluation, utilized by thousands of providers across over 50 countries [2]. - In the past five years, iCAD has estimated reading over 40 million mammograms globally, with nearly 30% being tomosynthesis [2].